Literature DB >> 28598045

Soft Drinks Consumption and the Risk of Nonalcoholic Fatty Liver Disease.

Zeba Siddiqi1, Ritu Karoli2, Jalees Fatima3, Sachin Khanduri4, Shishir Varshneya5, Sara Sabina Ahmad6.   

Abstract

INTRODUCTION: The increased consumption of sugar-sweetened beverages (SSBs) has been implicated in the increased incidence of obesity and metabolic syndrome Little of the research on sugar-sweetened beverage intake has examined the consumption patterns of sugared beverages by college students, despite the vulnerabilities of this population to weight gain. The current study sought to characterize sugar-sweetened beverage intake of undergraduate students who belong to high socio-economic strata and to study its correlation with presence of non-alcoholic fatty liver disease.
MATERIAL AND METHODS: In a cross sectional, a self reported questionnaire based study about soft drink consumption (≥2/day, 1/day, <1/day). That included undergraduate medical students. Anthropometry and blood pressure were recorded and fasting glucose, insulin and lipid profile and abdominal ultrasonography for the presence of fatty liver was assessed.
RESULTS: A total of 242 students were studied. The students in group 1 (≥2/day) had significantly higher BMI, waist circumference and diastolic blood pressure than students of other groups. They also had higher triglycerides, fasting insulin, HOMA-IR and significantly lower levels of HDL-cholesterol. Overall (40%) students had metabolic syndromes in group 1 compared to 8% and 3% in other groups while presence of NAFLD was observed in 75%, 16% and 4% in three groups respectively. Duration of soft drink consumption had positive correlation with presence of NAFLD.
CONCLUSIONS: Substantial consumption of soft drinks is leading to increased obesity and cardio-metabolic risk factors in young adults. Artificially sweetened diet soft drinks have been posed as a healthier alternative due to their lack of calories but they do not guarantee protection against non-alcoholic fatty liver disease.

Entities:  

Mesh:

Year:  2017        PMID: 28598045

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

1.  Factors early in life associated with hepatic steatosis.

Authors:  Sabrina Xin Zi Quek; Eunice Xiang-Xuan Tan; Yi Ping Ren; Mark Muthiah; Evelyn Xiu Ling Loo; Elizabeth Huiwen Tham; Kewin Tien Ho Siah
Journal:  World J Hepatol       Date:  2022-06-27

2.  Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study.

Authors:  Xing Wang; Shiyu Lin; Shinan Gan; Yeqing Gu; Ying Yang; Qing Zhang; Li Liu; Ge Meng; Zhanxin Yao; Dong Zheng; Hongmei Wu; Shunming Zhang; Yawen Wang; Tingjing Zhang; Shaomei Sun; Qiyu Jia; Kun Song; Xiao-Hui Wu; Yuntang Wu; Kaijun Niu
Journal:  Eur J Clin Nutr       Date:  2021-04-09       Impact factor: 4.016

Review 3.  An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Brandon J Perumpail; Rosann Cholankeril; Eric R Yoo; Donghee Kim; Aijaz Ahmed
Journal:  Diseases       Date:  2017-10-22

4.  Fast Food Consumption, Liver Functions, and Change in Body Weight Among University Students: A Cross-Sectional Study.

Authors:  Moawiah Khatatbeh; Waleed Momani; Zaid Altaani; Reem Al Saad; Abdul Rahman Al Bourah
Journal:  Int J Prev Med       Date:  2021-09-21

Review 5.  Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.

Authors:  Sjaak Pouwels; Nasser Sakran; Yitka Graham; Angela Leal; Tadeja Pintar; Wah Yang; Radwan Kassir; Rishi Singhal; Kamal Mahawar; Dharmanand Ramnarain
Journal:  BMC Endocr Disord       Date:  2022-03-14       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.